POLISCOPE
Back to feed
FEDERALhearing transcript
High Impact

Senate Hearing on Alzheimer's Disease and Medicare Impact

Original title: ALZHEIMER'S DISEASE: THE STRUGGLE FOR FAMILIES, A LOOMING CRISIS FOR MEDICARE

January 1, 2017

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

The hearing highlights the fiscal strain Alzheimer's disease places on federal healthcare programs, as patients with the condition account for 20 percent of all spending despite representing only 10 percent of beneficiaries.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Medicare beneficiaries with Alzheimer's

These individuals are the primary subjects of the medical and financial data discussed regarding care costs and disease progression.

Family caregivers

Caregivers face emotional and financial burdens associated with providing care for individuals with Alzheimer's.

What changed

Last recorded activity January 1, 2017.

What's next

Next step not available in the current record.

Summary

This Senate Subcommittee on Health Care hearing examined the medical and financial challenges posed by Alzheimer's disease. Witnesses and senators discussed the disease's status as a leading cause of death and its significant economic impact on the and programs.

Key Facts

  • Approximately 5.2 million Americans are estimated to have Alzheimer's disease.
  • Alzheimer's disease is the sixth leading cause of death in the United States.
  • Medicare and Medicaid combined spend over $160 billion annually on Alzheimer's care.
  • Patients with Alzheimer's represent 10 percent of Medicare beneficiaries but account for 20 percent of total Medicare spending.
  • There is currently no known cure or treatment for Alzheimer's disease.

Why It Matters

The hearing highlights the fiscal strain Alzheimer's disease places on federal healthcare programs, as patients with the condition account for 20 percent of all spending despite representing only 10 percent of beneficiaries.

Frequently Asked Questions

How many people in the U.S. have Alzheimer's?
It is estimated that 5.2 million Americans are living with the disease.
What is the financial impact of Alzheimer's on Medicare?
While Alzheimer's patients make up 10 percent of beneficiaries, they consume 20 percent of all Medicare spending.

News Coverage

Sponsors

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Focus on Alzheimer's as a fiscal crisis

The hearing frames Alzheimer's not just as a medical issue, but as a primary driver of Medicare insolvency, shifting the policy conversation toward economic sustainability.

Connected Entities

personConnie B. KarasowCaregiverMap →
personRonald C. PetersenChair, Advisory Council on Research, Care, and ServicesMap →
personDebbie StabenowU.S. Senator from MichiganMap →
personPatrick J. ToomeyChairman of the Subcommittee on Health CareMap →
organizationMedicaidFederal-state health assistance programMap →
organizationMedicareFederal health insurance programMap →
personHenry L. PaulsonDirector, Michigan Alzheimer's Disease CenterMap →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100
  • Significance80
    How much this matters to a regular citizen
  • Controversy20
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz15
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record